You are currently viewing a new version of our website. To view the old version click .

Genomics and Epigenetics of Rare Tumors

This special issue belongs to the section “Molecular Genetics and Genomics“.

Special Issue Information

Dear Colleagues,

Better approaches to diagnosing and treating rare cancers are urgently needed, because treatments for many rare cancers have not advanced at the same pace as treatments for more common cancers. Genomic medicine is transforming our understanding of cancer’s origins and complexity by providing detailed characterizations of cancer development in an individual. As well as advancing our understanding of what causes each person’s cancer, genomics is providing insights into how an individual’s cancer might progress, and its likely response to treatment. Genomic and epigenomic profiling of rare tumors and cancers—which collectively account for a significant proportion of cancer diagnoses—has the potential to improve a patient's diagnosis and treatment.

This Special Issue of the International Journal of Molecular Sciences is dedicated to the genomics and epigenetics of rare cancers, and welcomes reviews and original papers covering recent genomic and epigenomic research on rare tumor and cancers, including solid and hematological malignancies, pediatric cancers, and tumor predisposition syndromes; case reports highlighting genomic medicine approaches that can be utilized in several clinical scenarios may also be considered.

Dr. Camille Tlemsani
Dr. Eric Pasmant
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Genomics and epigenomics
  • Rare tumors and cancers
  • Precision therapy
  • Genomic medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Mol. Sci. - ISSN 1422-0067